Trump’s FDA nominee faces Senate questions after agency layoffs and resignations
President Donald Trump’s pick to lead the Food and Drug Administration is set to answer Senate questions Thursday about his plans for the agency, which may soon be at the center of an administration plan to scrutinize vaccines, antidepressants and ultraprocessed foods.
Days after the U.S. FDA cancelled an annual meeting to discuss the makeup of the following season's flu vaccine, FDA ...
Dr. Marty Makary will testify before the Senate health committee on Thursday. Lawmakers may press him over staff reductions ...
The Trump Administration reversed course on plans to terminate the lease of a major Food and Drug Administration quality lab ...
Marty Makary, President Donald Trump’s pick to oversee US food and drug regulation, faced pointed questions in a Senate ...
If confirmed to lead the Food and Drug Administration, will Dr. Marty Makary carry out Robert F. Kennedy Jr.’s plans to ...
The Senate hearing for FDA Commissioner nominee Marty Makary comes after President Trump's NIH pick, Jay Bhattacharya, was ...
Elsewhere in the obesity space — Amgen has initiated Phase 3 trials of its obesity drug MariTide, one in overweight and obese people without diabetes and another one for people with diabetes.
Dr. Marty Makary, President Donald Trump’s pick to lead the FDA, will face the lawmakers standing between him and Senate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback